Navigation Links
Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement
Date:9/27/2010

Institute of Medical Research

The Garvan Institute of Medical Research is a world class institute focused on gene-based medical research with a strong focus on cancer and metabolic syndromes. World leading DNA methylation researcher Professor Susan Clark is the director of epigenetics research at the Garvan. Prof. Clark's track record includes pioneering the development of the bisulphite sequence protocol for detecting methylated cytosines now used around the world to measure gene silencing, discovery of the hyper-methylation of GSTP1 in prostate cancer and, more recently, contributions to understanding genome-wide methylation patterns in cancer.

About Clinical Genomics Pty Ltd

Clinical Genomics was formed in September 2006 to develop, extend, and commercialise molecular markers for colorectal disease. The enterprise includes experts in the science and business of colorectal cancer detection as well as institutional, commercial and clinical collaborative partners that understand this field. On top of a solid foundation of intellectual property protecting a panel of neoplasia biomarkers, CG has attracted significant financial and human resources to address this opportunity. By applying advanced biotechnology and computational technologies to study the complex changes in gene expression that occur as normal colorectal cells become cancerous, Clinical Genomics expect that an understanding of the molecular basis of the disease will enable them to provide products for improved diagnosis, management and possibly therapy of this disease.   Further Information:   Dr. Lindsay Collinson   Ph: +61 2 9888 9065 x 206   E: Lindsay.collinson@clinicalgenomics.com   Clinical Genomics Pty Ltd
'/>"/>

SOURCE Clinical Genomics Pty Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
2. Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis
3. China Pharma Holdings, Inc. Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
4. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
5. Santaris Pharma A/S Advances miravirsen, the First microRNA-Targeted Drug to Enter Clinical Trials, Into Phase 2 to Treat Patients Infected With Hepatitis C Virus
6. 2010 Lasker Awards Honor Trailblazers in Medical Research and Clinical Care
7. Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC
8. Stemedica Announces Completion of Clinical Stem Cell Master Bank
9. Paratek to Present Clinical Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. ChromaDex Commences a Clinical Trial on pTeroPure™ Pterostilbene
11. InSightec Treats First Prostate Cancer Patients in Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... clinical grade hypothermic storage and cryopreservation freeze ... cells and tissues  ("BioLife" or the "Company"), today announced that ... May 4, 2015 (the "Annual Meeting"). Because the ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Stem Cell Technology Center, LLC ( ASCTC ) focused attention ... adult tissue stem cells. His title “Asymmetric Self-Renewal by ... Future,” embodied the essence of his message to congress participants. ...
(Date:12/24/2014)... 23, 2014 According to Ross Selinger, President ... of ITRA Global, the national office market continues to be ... This is evidenced by the third quarter’s surprising 3.9% GDP, ... Low energy costs have held inflation down and the Fed ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... Sinovac Biotech Ltd. (Amex:,SVA), a leading provider of ... Health has purchased approximately RMB 20 million (US$2.86,million) ... to,vaccinate people living in the disaster zone following ... the Healive vaccine to,Sichuan, Shanxi and Gansu provinces., ...
... (NYSE: SGP ) today announced that ... investor relations, effective immediately., In this ... implementing,and continually improving a comprehensive global investor ... formulation and execution of,external and internal investor ...
... American Stock Exchange(R),(Amex(R)) today listed the common ... symbol RNN., Rexahn Pharmaceuticals is a ... discover, develop and commercialize,innovative treatments for cancer, ... unmet medical needs. Rexahn,s compounds are designed,to ...
Cached Biology Technology:Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims 2Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations 2American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc. 2
(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... Conn. , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: ... mobile commerce market, reports on the recent success of the Wocket™ smart ... Wocket smart wallet was named as one of the "11 ... the "5 Best Products Launched At CES So Far" by Newseveryday.com and ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... gets older, people live longer. The price we pay: ... all organs, the immune system does not function flawlessly ... non-university research institutes and two companies is investigating why ... old. The project "GERONTOSHIELD", funded by the German Federal ...
... Researchers with the International Agency for Research on Cancer ... significantly more likely to have several high-risk forms of ... not have lung cancer. These results, which were presented ... 2-6, indicate that HPV antibodies are substantially increased in ...
... particles only billionths of a meter in diameterabout two thousand would ... in a small package to the many millions of people who ... and cell phones, say scientists at Brigham and Women,s Hospital (BWH). ... the team will report a new approach to preventing the ...
Cached Biology News:A better understanding of the aging immune system 2Lung cancer risk rises in the presence of HPV antibodies 2Nanoparticles offer hope for common skin allergy 2Nanoparticles offer hope for common skin allergy 3
... Select Tissue Arrays are intended for laboratory ... were fixed in neutral buffered formalin and ... diagnosis was performed by certified pathologists. ... blocks and relocated into a new recipient ...
The Odyssey Infrared Imaging System is a complete family of products that includes the Odyssey Imager, IRDye labeling reagents and Odyssey software for scan control and data analysis....
... CAST Equine EIA Principle: ... LTC4, LTD4 and LTE4 are ... by 5-lipoxygenase and glutathione-S-transferase. In ... termed "Slow Reacting Substances of ...
... Compound(s) tested through 63 ... assays spanning a broad ... panel includes many non ... several non-selective assays. ...
Biology Products: